Funding for this research was provided by:
National Institute on Aging (R01AG054214, K99 AG053439)
National Institute of Neurological Disorders and Stroke (R01NS059690, U54NS100717)
Text and Data Mining valid from 2020-01-06
Received: 21 August 2019
Accepted: 19 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: All participants in the human study provided written and informed consent, and the institutional review board of UCSF approved all studies.
: Not applicable.
: L. G. is a founder of Aeton Therapeutics.